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Transcytosis is the process by which macromolecules are transported across a 
polarized cell.  It is one of the main methods of nutrient absorption from the blood stream 
as well as the only means past the blood brain barrier.  Insight into the transcytic route 
has enormous medical potential where drug delivery methods stand to be significantly 
optimized.  Despite the importance of this fundamental biological process, the 
mechanism of transcytosis is not well understood.  Previously, fluorescence microscopy 
has allowed the tracking of fluorescently labeled low-density lipoprotein (LDL) 
intracellularly.  However, this labeled LDL is not able to distinguish LDL particles 
undergoing transcytosis versus degradation.  LDL is an ideal cargo for observing 
intracellular processes due to its vital role in transporting cholesterol for cell membrane 
fluidity.  In order to differentiate transcytosis from degradation, I have produced two 
probes sensitive to degradation.  The two probes are based on the principles of 1.) Förster 
resonance energy transfer (FRET) and 2.) fluorescence quenching.  LDL degradation of 
the FRET-based or the fluorescence-quenching-based probe results in a significant 
increase in fluorescent activity. I have used several methods to assess the functionality of 
these probes including fluorescence measurements of detergent and enzyme degradations, 
SDS-PAGE analysis of degradations, and in vivo  flow cytometry.  Additionally, I have 
optimized the growth conditions for maintaining polarity in a cell line (MDCK) known to 
undergo transcytosis.  The time and location of LDL degradation in a cell can be resolved 
through the use of these probes.  Future work includes single-particle tracking of LDL as 
 xi
it is being degraded versus actively transcytosing across a cell layer.  This process is 





Transcytosis is the process by which macromolecules are transported across a 
polarized cell.  It is a fundamental practice of all multicellular organisms as nutrient 
cargo needs to be distributed through many cell layers.  Cells that undergo transcytosis 
regulate how much cargo is retained and degraded for individual cell use and how much 
is transported across to underlying tissues.  The mechanism by which cells sort cargo 
between these pathways as well as efficiently transport cargo-containing vesicles across 
the length of the cell remains poorly characterized.  In addition to determining how such 
regulation is achieved, understanding the transcytic route would have an extreme impact 
in pharmaceutical design; drugs could be optimized to enter the transcytic rather than the 
degradative route in cells.  Additionally, transcytosis is the only method of entry past the 
blood brain barrier into the central nervous system.  The blood brain barrier represents 
one of the most highly regulated areas of cellular transport (1).  Insight into how 
transcytic regulation is performed in the blood brain barrier would allow for treatment of 
central nervous system disorders, such as Alzheimer’s and Parkinson’s disease.    
Resolving transcytosis has the potential to portray the details of a characteristic 
multicellular organism process.  Such knowledge can be directly applied to drug delivery 
design and metabolic intracellular regulation.  
Significance of Transcytosis 
Transcytosis involves active transport of cargo in vesicles across a cell.  This 
mechanism involves endocytosis from one distinct surface and exocytosis from another 
site.  A classic example of transcytosis occurs in epithelial cells when macromolecules 
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are endocytosed from the blood vessel at the apical surface and exocytosed at the 
basolateral surface to the underlying tissues.  This process was initially described for its 
role in the immune response, as immunoglobulin undergoes receptor-mediated 
transcytosis to pass through cell layers (2). Medically, transcytosis is the center of 
enormous research efforts that seek to take advantage of natural cell transporting 
mechanisms for better drug uptake and efficiency.  Transcytosis is, however, critical for 
more than just transport, as it also exists to establish cell polarity and to deliver proteins 
to the apical surface.  Transcytosis is a key feature of any polarized cell or multicellular 
organism.  Despite being a major pathway for membrane trafficking the specific 
mechanism by which transcytosis occurs remains debated. 
 Previously, transcytosis was described as a unique and completely devoted 
pathway in the cell (2).  It was hypothesized to involve a special transcytic endosome that 
traveled the entire cell and directly fused to the opposite membrane.  It has recently been 
shown that transcytosis more likely occurs by a combination of endo- and exocytic 
processes (3).  In this manner, cellular components used for non-transcytic transport 
processes are utilized.  A limitation of both of these conclusions results from the manner 
of inferring verification by elimination of the alternative.  This indirect approach is very 
useful, but as of yet, no spatio-temporal model of transcytosis has been verified directly.   
 The goal of this research was to design and test the functionality of two probes for 
the use of tracking LDL transcytosis in polarized cells.    These probes are sensitive to 
their environment, and display a distinct increase in fluorescent activity when exposed to 
degrading enzymes. This change in fluorescent activity is based on two principles for the 
two respective probes: 1.) Förster resonance energy transfer (FRET) and 2.) quenching.  
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The two probes will visualize transcytosis by distinguishing LDL particles that are 
undergoing a competing process of degradation. These probes are capable of elucidating 
the spatial and temporal kinetics of LDL transcytosis.  By determining how this process 
occurs, it will be possible to understand the fundamental biological question of how 
macromolecules are transported across a cell.  Additionally, such knowledge will allow 
for massive progress in the field of drug delivery where the transcytic route could be 
recruited for drug transport to specific tissues.  
LDL as a Model Transcytic Cargo 
  Low-density lipoprotein (LDL) is an ideal cargo for studying transcytosis due to 
its medical significance as well as advantageous physical structure (4).  LDL, though 
infamous for its role in atherosclerosis, is essential to cellular function (5-7).  LDL is 
biologically significant because it is the primary transporter of cholesterol from the liver 
to the peripheral tissues.  Cholesterol is required to maintain the fluidity of the cell 
membrane and influences all membrane signaling and transport mechanisms (6).  Due to 
the cellular importance of LDL, it is often used as a form of cargo that is readily 
visualized after staining with common fluorescent dyes.  In order to stain the LDL 
particle, dyes take advantage of general LDL morphology.  The core of LDL consists of 
hydrophobic cholesteryl esters and triacylglycerides and is surrounded by a phospholipid 
monolayer with free-floating unesterified cholesterol.  Apolipoprotein B100 on the 
surface of the particle is responsible for recognition of the LDL particle to cell surface 
receptors (8).  Currently, no structure exists for apolipoprotein B100, and modeling 
experiments have determined that only two of seven domains are embedded in the LDL 
core (9). The remainder of the domains is estimated to rest on the phospholipid 
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monolayer and maintain particle integrity.  LDL integrity is lost with cleavage of 
apolipoprotein B100. 
LDL taken in by the cell can be transported across an epithelial cell layer to be 
distributed to underlying tissues, such as the endothelial cells that line blood vessels.  It is 
a representative marker for visualizing transcytosis.  Additionally, LDL can be actively 
degraded by a transporting cell for the cell’s own personal use. The trafficking process 
for LDL begins after endocytosis from the blood stream by LDL receptors.  As the LDL 
travels intracellularly in the maturing endosome the pH decreases and causes release of 
the receptor-bound LDL particle.  Once within the lysosome, LDL degradation begins to 
occur within 30 minutes to 2 hours (10).  The lysosomal enzyme initially responsible for 
this degradation is cathepsin D, an aspartic protease known to produce many high-weight 
molecular fragments indicative of intermediate LDL degradation (11).  Further 
degradation of LDL in the lysosome requires other thiol proteases, chief of which is 
cathepsin B (11, 12). Cathepsin B is known to produce many low molecular weight bands 
characteristic of a more thorough and efficient protease (11, 12).  Both of these enzymes 
appear to cleave at distinct sites; however, the sites for each enzyme are not consistent 
with a particular residue sequence (12). 
Previous Work on LDL Transcytosis. 
Much of the knowledge of LDL degradation and cellular events comes from 
isotopic studies of 125I-labeled LDL and gel electrophoresis, where only bulk rates of 
degradation can be found at relatively long time scales.  This method was one of the first 
employed for analysis of LDL degradation, and further studies characterizing LDL 




Figure 1.  Transcytic Route versus Degradative Route of Intracellular LDL. This 
diagram depicts LDL intracellular pathways in the context of endothelial cells; this 
example is applicable to understanding the mechanism of transcytosis in the blood brain 
barrier.  From the blood vessel, LDL binds to receptors on the endothelial cell surface.  The 
LDL-receptors are endocytosed into vesicles known as early endosomes.  From there, the 
most well-characterized pathway of LDL is degradation.  LDL-containing early endsomes 
mature into late endosomes accompanied by a decrease in pH that disassociates the LDL 
cargo from its receptor,  The LDL cargo is then exposed to proteases and lipases in the 
lysosome and enzymatic degradation of the particle occurs.  Alternatively, LDL in 
endothelial cells or epithelial cells can be actively transported across the cell layer via 
transcytosis.  Tbe mechanism, vesicles, and active transporters are not well characterized in 






















observes the behavior of the apolipoprotein B100 and infers LDL interactions from this 
behavior.  However, the distribution of cholesterol would be expected to change in the 
LDL particle as the transporter protein is cleaved, and tracking LDL degradation in this 
manner does not prove efficient.  However, many assays are currently performed using 
fluorescently labeled LDL as an indicator of proper endocytosis and cellular functioning.  
Fluorescent tracking of molecules is highly sensitive and allows for dynamic, in vivo 
knowledge of interactions to be observed.  One color labeled LDL is the current standard 
for observing LDL inter- and intra-cellular localization (14). Previous data demonstrates 
that this technique accurately portrays trafficking mechanisms of the LDL cargo (15).  
However, the one color labeled LDL does not yield any knowledge of the environment of 
the LDL cargo during transcytosis, such as a degrading scenario.  The probes developed 
in this study can observe LDL degradation based on Förster resonance energy transfer 
(FRET, Figure 2) as well as fluorescence quenching. The lipophilic DiI and DiD were 
chosen due to their lipophilic nature; these particular fluorophores insert into the 
phospholipid monolayer of the LDL particle, representatively mimicking the behavior of 
cholesterol being carried in the same phospholipid monolayer.  These fluorophores also 
fit the spectral overlap criteria for FRET where the emission overlap of DiI, the donor, 
overlaps with the absorption spectrum of DiD, the acceptor.  This technique should yield 
data that better depicts the molecular interactions of cholesterol, which is the most 
biologically significant component of the LDL particle. 
Principles of LDL Probe 1: Förster resonance energy transfer 
Based on the spherical nature of the LDL particle, and the non-linear decrease in 
surface area as volume decreases, it was hypothesized that degradation in an LDL particle 
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would be observed as a decrease in FRET signal (Figure 3).  This relies on previous 
dynamic light scattering results that indicate smaller volume particles resulting from 
enzymatic degradation of apolipoprotein B100 (12).  These smaller volume particles 
would have a larger surface area to volume ratio than the starting LDL particle, and the 
probability for FRET interactions should decrease with degradation.  This lower 
probability of FRET interactions manifests itself as an increase in the donor emission to  
acceptor emission, as the fluorophores are not in close enough proximity to undergo 
energy transfer and the donor undergoes photon emission rather than energy transfer. 
Only one group has attempted a similar protocol, G. Ouedraogo and R. Santus at the 
Institut de Recherche sur la Peau in Paris, France, when quantifying photolysis of 
lysosomal contents as inferred from a decrease in FRET (16).  However, this FRET 
decrease was based on the light catalyzed destruction of the lysosome and its contents by 
the photosensitive antibiotic fluoroquinolones.  FRET has not been used previously to 
observe the enzymatic degradation of LDL.  Currently, the probes designed for this thesis 
undergo a decrease in FRET signal upon incubation of the LDL molecule with lysosomal 
and non-lysosomal enzymes, verifying the validity of the hypothesis. 
Principles of LDL Probe 2: Fluorescence Quenching 
The sensitivity of the fluorescence quenching probe also relies on the three-
dimensional nature of the LDL particle and the non-linear decrease in surface area as 
volume decreases.  Normally, fluorescence is characterized by excitation from a light that 
causes photon absorption and emission of longer wavelength photons.  Fluorescence is 
known as a form of radiative decay where the energy absorbed from the light in the form 
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Figure 2.  Principles of FRET.  FRET is observed to occur when there is significant spectral overlap 
between the donor and acceptor dyes and a short distance between them.  (A) The donor and acceptor 
dyes used in this experiment have spectral overlap.  (B) FRET efficiency is higher when the donor and 
acceptor dyes are in close proximity; acceptor emission is observed even when using the donor excitation 
wavelength.  (C) A larger distance between the donor and acceptor dye results in inefficient energy 
transfer; in this case, donor excitation results simply in donor emission.  (D, E) The donor-acceptor 





































Figure 3.  Mechanism of FRET probe.  The lipophilic dyes embed themselves in the phospholipid 
monolayer that coats the LDL particle.  (A) The intact LDL particle is characterized as having a lower 
surface area to volume ratio than the degradation products.  This feature implies that dye molecules will 
have a higher probability of encountering each other and a higher FRET efficiency in the intact LDL 
particle.  As degradation occurs the dye molecules will have a lower probability of encountering one 
another and donor emission will increase as acceptor emission decreases.  (B) The average dye distance 
and corresponding fluorescence intensity graphs are shown to exemplify the data predicted during LDL 
degradation. 
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emission is not possible – an effect described as quenching.  Instead, the energy is lost 
through non-radiative decay, such as transfer of energy to non-fluorophore molecules 
through collisions.  Dyes at a high concentration are observed to increase significantly in 
fluorescence intensity as the concentration decreases to some determined threshold value.  
Fluorescence quenching is often taken advantage of in fluorescence microscopy.  In 
terms of an LDL probe, fluorescence intensity is hypothesized to significantly increase 
upon degradation due to the large increase in the surface-to-volume ratio.  This 
hypothesis was confirmed in this study, indicating that a fluorescence-quenching-based 
LDL probe would also be a useful tool for visualizing transcytosis.  The fluorescence 
quenching technique has advantages over one-color labeling techniques, or even FRET, 
because an increase in fluorescence intensity is extremely less likely to occur than a 
decrease in fluorescence intensity.  A decrease in fluorescence intensity can result from 
photobleaching of the fluorophore or the fluorophore moving out of the focus of the 
microscope; however, an increase in fluorescence intensity is rarely observed.  A huge 
increase in the signal-to-noise ratio when tracking these fluorescence-quenching-based 
LDL probes should be gained. 
Madin-Darby Canine Kidney Cells as a Model Cell Line for Transcytosis 
Transcytosis is a process characteristic of multicellular organisms (17).  Nutrients 
require transport through cell layers in order to be distributed throughout tissues.  The 
cells primarily responsible for transcytosis are epithelial cells; these cells line the internal 
side of all organs.  Epithelial cells that line the blood vessels are a specialized form of 
epithelium known as endothelial cells (18).  Transcytosis is critical for both nutrient 
distribution by the endothelial cells as well as macromolecule trafficking for the epithelial 
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cells that line the lumen of organs such as the liver, kidney, and gastrointestinal tract.  For 
the endothelial cells, the polarized cell surfaces necessary for transcytosis are the apical 
and basolateral surface.  The apical surface is defined as the surface that contacts the 
lumen of the blood vessel while the basolateral surface contacts the underlying tissues.  
For epithelial cells, the apical surface contacts the lumen of the organ while the 
basolateral surface absorbs macromolecules from underlying endothelial tissue. 
Madin-Darby canine kidney cells (MDCK) were isolated from a female cocker 
spaniel in 1953 (19).  These cells were initially harvested for the large electrical 
resistance produced when a current was applied across the monolayer.  The characteristic 
high electrical resistance of these cells was a result of numerous tight-junctions that 
prevent paracellular movement, movement between cells, of molecules.  Ions and other 
charged molecules are trapped on the distinct apical and basolateral sides of the cell 
monolayer inhibiting current flow and producing an electrical resistance comparable only 
to blood brain barrier cells.  When paracellular transport of macromolecules is not 
possible, transcytosis becomes the only significant route of macromolecule trafficking; 
this is the case for the blood brain barrier cells and a similar situation for MDCK (20).  
MDCK cells are an excellent model system for studying transcytosis.  These cells are 
easy to culture and ensure polarization.  Protocols have already been developed in order 
to induce and verify proper polarization of the cell monolayer (21). 
Applications of LDL Probes 
The results of the LDL probes establish an excellent technique for future in vivo, 
dynamic, single-molecule tracking of LDL during transcytosis.  FRET and fluorescence 
quenching are poised to become a comprehensive labeling technique for cholesterol-
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representative, dynamic, well-resolved imaging that confers structural characteristics of 
single particles.  This is because traditional labeling methods, crystallization techniques, 
and standard protein or lipid protocols have shown poor to no yields for characterizing 
LDL structural qualities.  The two LDL probes should serve as single-particle tracking 
tools for high resolution in vivo LDL localization and degradation.  Intracellular 
movement of the LDL particle from the endosomes to the lysosomes, a poorly 
characterized process, can now be dynamically imaged and quantified using these probes.  
Transcytosis can also be clearly elucidated using these degradation-sensitive LDL probes. 
The goal of this research was to design and test the functionality of two probes for the use 





EXPERIMENTAL METHODS  
The probes were designed to have an increase in fluorescent activity upon 
degradation of the LDL particle.   This initially required optimizing the fluorescent 
labeling of the LDL in order to get maximum FRET efficiency and quenching values 
with the intact LDL particle.  An in vitro functionality test of the probe involved 
degradation via detergent and enzymes.  An SDS-PAGE was used to confirm the results 
of the enzymatic degradation.  An in vivo determination of probe functionality was 
performed via flow cytometry.  The cell line known to undergo transcytosis was also 
fully characterized for proper polarization. 
Materials 
Human low density lipoprotein was obtained from Cappel (MP Biomedicals). The 
fluorescent, lipophilic fluorophores DiI (1,1’- dioctadecyl - 3,3,3’,3’-tetramethylin-
docarbocyanine perchlorate) and DiD  (1,1'- dioctadecyl-3,3,3',3'- tetramethylin-
dodicarbocyanine, 4-chlorobenzenesulfonate salt) were obtained from Molecular Probes 
(Invitrogen).  These dyes were chosen due to their lipophilic nature and overlapping 
emission/absorption spectra.  Lyophilized cathepsin B, cathepsin D, trypsin and 
chymotrypsin all came from Sigma-Aldrich. GE Healthcare illustra™ NAP-5 size 
exclusion chromatography columns were used to clean excess dye from the LDL 
particles.  Cell lines were obtained from ATCC.  All cell culture materials, including 
growth media, antibodies and fluid-phase markers, were obtained from Invitrogen except 
for the Transwell Filters (Corning). 
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Fluorescent Labeling of LDL 
LDL (250 µg) was incubated with various amounts of dye depending on the 
probe.  For FRET, 110 dye particles per LDL particle were used in a ratio so that the 
molar absorptivities of each dye were equal between donor (ε ~ 8000 L * mol-1 * cm-1) 
and acceptor (ε =  2036 L * mol-1 * cm-1).  This amounted to 82 acceptor molecules of 
DiD and 28 donor molecules of DiI per LDL particle.  For the fluorescence quenching 
probe, the acceptor dye, DiD, was used at 28 molecules per LDL particle.  Higher dye 
concentrations were observed to fully saturate the LDL particle as evidenced by a gross 
excess of dye during size exclusion chromatography.  It was not possible to visually 
assess saturation of the lower dye concentrations in LDL.  Different mixtures of dye were 
prepared in a DMSO stock solution.  Various ratios were tested due to previous research 
emphasizing DiI having a magnitude greater absorbance and emission intensity than DiD 
(12).  The incubation period involved gentle pipetting of the sample every ten minutes for 
an hour.  Samples were then cleaned using a size exclusion chromatography column and 
measured for concentration by absorbance.  When an absorbance concentration was not 
possible, concentration was estimated to be the determined average percent yield of the 
column (~75%). 
Degradation of LDL Particle via Detergent and Enzymes 
Sorenson’s buffer, consisting of 0.1 M phosphate pH 7.4, 1 mM EDTA, and 1 
mM dithiothriotol was used for digest reactions at the physiological pH of blood.  A 0.1 
M sodium acetate buffer, 1 mM EDTA and 1 mM dithiothriotol, pH 5.5 was used for 
reactions at lysosomal pH.  Detergent degradation was carried out under the two different 
pH values with 1% Triton-X 100 and a 30 minute incubation at 37°C. For all 
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degradations, 500 µg/mL of LDL was used in a total volume of 100µL.  Enzymatic 
degradation had an additional 40 μg/ml of enzyme.  Degradation with trypsin was at the 
physiological pH of the blood, 7.4; cathepsin B degradation was at the lysosomal pH 5.5.  
As a control, chymotrypsin and cathepsin D degradations were observed to yield similar 
results and only replicates of trypsin and cathepsin B were performed (data not 
shown)(22). The enzymatic degradations were incubated for 2 hours at 37°C and the 
reaction was then stored at 4°C.  As a control, all degradation reactions were compared to 
a similarly incubated but non-detergent/enzyme exposed labeled LDL sample.  
Spectroscopic measurements were taken as soon as possible and small aliquots of the 
digest were taken for SDS-PAGE analysis.  
Visualization of Enzymatic Degradation via SDS-PAGE 
Gel electrophoresis was performed to confirm the degradation of LDL.  Samples 
were prepared using a 1:1 ratio of Laemmli Sample buffer (1.5 M Tris-HCl, bromophenol 
blue, 15% glycerol, 5% β-mercaptoethanol) and boiled for 5 minutes prior to loading.  An 
SDS-PAGE composed of 5 varying acrylamide bands (4, 8, 12, 16, 20% respectively) 
was prepared for electrophoresis in a Mini-Protean 3 gel electrophoresis system (Bio-
Rad).   High range and low range molecular weight markers from Bio-Rad were also 
used.  The voltage was a constant 120 V run for one hour, and staining and destaining 
were performed overnight. 
Spectroscopic Measurements 
Absorbance measurements were taken in a Beckman Coulter DU® 800 
spectrophotometer with a Beckman Coulter 50 µL UV silica cuvette (path length: 10 mm, 
path width: 2.0 mm).  Fluorescence emission measurements were taken in a Shimadzu 
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RF-5301 PC spectrofluorophotometer in a Hellma 50 µL quartz cuvette (type no: 
105.254-QS, light path: 3 mm).  LDL concentration was determined at an absorbance of 
271 nm.  DiI, the FRET donor fluorophore, had a maximum absorbance at 554 nm, 
however, an excitation wavelength of 530 nm was used to avoid exciting the acceptor 
dye.  The maximum emission for DiI was 580 nm.  DiD maximum absorbance occurred 
at 648 nm, but an excitation wavelength of 630 nm was used to better resolve the 
maximum emission at 670 nm.  When lipids were absent, DiD was verified to be non-
fluorescent while DiI was determined to be weakly fluorescent (data not shown).  FRET 
calculations were made by comparing donor emission at 580 nm to acceptor emission at 
670 nm.  An increase in FRET signal would be seen as a decrease in the ratio of donor 
emission to acceptor emission.  A change in quenching was observed as an increase in 
fluorescence intensity after degradation and these measurements often required multiple 
dilutions to prevent detector saturation. The presence of the fluorophores was verified 
throughout the experiment by taking the absorbance of all solutions. 
Cell Culture  
MDCK type II cells (ATCC CCL-34TM) were propagated in Eagle’s Minimal 
Essential Medium with 10% (v/v) fetal bovine serum in a 5% CO2 atmosphere at 37˚C.  
Cells had the medium replaced daily and were split every 3-4 days.  In order to break up 
the tight monolayer, splitting involved rinsing once and incubating for approximately 15 
minutes with a trypsin-EDTA mixture (2.5 g/L trypsin, 0.38 g/L EDTA·4Na, 60.000 g/L 
NaCl, 4.000 g/L KCl, 0.600 g/L KH2PO4, 0.479 g/L Na2HPO4, 0.100 g/L Sodium-salt 
phenol red).  For use in transcytic assays, cells were seeded on 0.4 μm pore-sized 
Corning Transwell-clear filters (12 and 24 mm diameter for 12 and 6-well plates 
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respectively) so that confluence was reached within 2 days.  Another cell line, BS-C-1 
(ATCC CCL-26TM), was used for simple flow cytometry experiments. The BS-C-1 cells 
were grown under similar conditions as MDCK without the Transwell filters. 
Determining MDCK Polarization 
Kidney epithelial cells require polarization of the cell surface before transcytosis 
can properly occur  (10, 23-27).  This involves the formation of distinct apical and 
basolateral domains that are separated by the numerous tight junctions.  Three methods of 
assaying MDCK polarization were used.  Cells were grown for at least 2 days before 
measurements.  A Millipore Millicell transepithelial resistance (TEER) device was used 
to measure characteristic TEER values of the cell monolayer (23, 24, 28, 29).  Polarized 
tight junction formation also inhibits paracellular leakage (30).  Paracellular leakage can 
be detected with a  monolayer integrity test (24).  This measures the monolayer rejection 
of rhodamine-dextran (tetra-methyl-rhodamine), a fluid-phase marker, when cells are 
grown on the Transwell filters.  Additionally, immunostaining via FITC-conjugated-α-
tubulin was used to look for characteristic reorganization of the microtubule cytoskeleton 
(24).  This assay involved seeding a glass-well plate in a similar method as seeding the 
Transwell filters. 
Testing LDL Quenching Probe in vivo by Flow Cytometry 
 An in vivo analysis of probe functionality used a flow cytometer (Becton 
Dickinson FACS Vantage SE).  BS-C-1 cells were grown to confluence for 5 days before 
LDL labeling began.  The cells were incubated on ice for 10 minutes, and then incubated 
an additional 10 minutes on ice with 14.3 µg of LDL labeled with the quenching probe in 
fresh cold medium.  The cells were then rinsed and incubated for the designated time.  
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Cells were rinsed twice with Liebovitz medium before collecting for flow cytometry via 




Determination of Labeled LDL Concentration 
A standard curve was generated in order to determine concentrations of the 
column-cleaned labeled LDL to use in the digests (Figure 4A).  It was found that the dye 
altered the absorbance reading in the 280 nm region of the LDL spectrum (Figure 4B).  
This discovery indicated that absorbance of the labeled LDL particle was not a reliable 
means of assessing concentration.  Instead, estimates of column-cleaned labeled LDL 
concentration were based on the average percent yield of the columns.  All degradations 
reactions used consistent volumes - 100 μL. 
In vitro Detergent Degradation of LDL Probes 
 As a control, the LDL probes were fully dissolved using Triton-X 100.  Triton-X 
100 is a non-ionic surfactant whose hydrophobic alkyl chain inserts into the LDL particle 
core.  Incubation of LDL with Triton-X 100 dissolves the intact LDL particle via the 
numerous competing hydrophobic interactions with the amphipathic detergent Triton-X 
100; this has previously been shown to abolish FRET efficiency (16).  All degradation 
assays were run alongside a sample of non-detergent exposed fluorescently labeled LDL 
to control for temperature and pH effects.  The resulting percent change after degradation 
was normalized to the control sample. 
Detergent Degradation of Probe 1: FRET Probe 
  Incubation at 37°C for 30 minutes in the absence of detergent and at either tested 
pH was found to increase FRET efficiency approximately 15% (data not shown). This 
result was most likely due to increasing movement of the lipophilic dyes on the surface 
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and the probability of them encountering one another.   The detergent-incubated dyes 
were normalized to the non-detergent-exposed FRET probes.  As predicted, detergent 
exposure reduced FRET efficiency of the FRET probes.  Due to the decrease in 
efficiency, the ratio of FRET shifts from a higher acceptor emission to a higher donor 
emission.    This was observed as an increase in the FRET ratio above the defined pre-
degradation value of 100% (Figure 5A).  The percent changes 142% and 240% were 
observed at a pH of 7 and 5 respectively, in the FRET ratio.  A 99% greater change was 
observed at pH 5 than pH 7 indicating enhanced degradation of LDL under lysosomal 
pH.   
Detergent Degradation of Probe 2: Quenching Probe 
The fluorescence quenching based probe was similarly tested for functionality.  
The non-detergent exposed control was observed to have an approximately 32% increase 
in fluorescence intensity at both pH values after the timed incubation (data not shown).  
This was in contrast to the enormous response for the detergent exposed quenching 
probe; fluorescence intensity changed over a magnitude (Figure 5B).  For a pH of 7, 
1900% percent change in the fluorescent intensity was observed.  At a pH of 5, 2390% 
increase in the fluorescence intensity was observed.  The lysosomal pH 5 had a percent 









Figure 4.  LDL Absorbance at 271 nm.  Absorbance at 271 nm was affected by 
LDL concentration as well as DiD dye concentration.  (A) A calibration curve 
shows the linear change in absorbance as LDL concentration was increased.  (B) 
LDL absorbance was also observed to have a linear logarithmic change as DiD was 
titrated into the sample. LDL concentration was held constant at 7.5 nmol. 
Change in LDL Absorbance with DiD Addition
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Figure 5.  In vitro Detergent Degradation of Probes.  Triton-X 100 was used to 
dissolve the LDL particles and sensitivity of the probes was measured as a percent 
change from starting values (100%).  (A) The FRET probe was observed to have an 
increase in the donor to acceptor emission ratio after degradation.  (B) The 
quenching probe was observed to have an enourmous increase in fluorescence 
intensity after degradation. 



































In vitro Enzymatic Degradation of LDL Probes 
 The probes were than analyzed for functionality in an in vitro enzyme digest.  
Trypsin was chosen as a general control enzyme commonly used in degradation assays.  
It performs ideally at a higher pH such as the pH of the bloodstream at 7.4.  Cathepsin B 
is a lysosomal thiol protease normally involved in LDL degradation within the lysosome.  
Cathepsin B works ideally at the pH of the lysosome, 5.5.  The samples were excited at 
the donor excitation wavelength, 530 nm, and emission was measured at 580 nm for the 
donor and 670 for the acceptor.   
Enzymatic Degradation of Probe 1: FRET Probe 
The FRET probe was observed to have an increase in the donor to acceptor 
emission ratio after cathepsin B treatment (Figure 6A).  After trypsin treatment, there was 
a decrease in the donor to acceptor emission ratio.   
Enzymatic Degradation of Probe 2: Quenching Probe 
The quenching probe was observed to have minimal increases after enzyme 
incubation.  
Visualization of Enzymatic Degradation via SDS-PAGE 
 After digestion, aliquots of the reaction sample were visualized on SDS-PAGE 
and degradation was confirmed (Figure 7).  LDL incubated in the absence of enzyme was 
observed to have 2-3 bands above 200 kDa, which previous data explains as 
apolipoprotein B or possibly E sometimes exiting the LDL particle.3,4  The enzymes 
displayed distinct banding patterns with trypsin producing the smallest products (Figure 
7B).  Bands were observed to become linearly fainter in the lanes containing increasing 























Figure 6.  In vitro Enzymatic Degradation of Probes.  LDL is normally broken 
down by lysomsomal enzymes so an in vitro single enzyme degradation was 
performed to test  probe functionality.  Functionality of the probes was measured as 
a percent change from starting values (100%).  (A) The FRET probe was observed 
to have an inconsistent response to enzyme degradation.  The quenching probe was 
observed to have a minimal increase in fluorescence intensity after degradation (B). 
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Testing LDL Quenching Probe in vivo via Flow Cytometry 
 A flow cytometer was used to rapidly measure the fluorescent intensity of 
numerous cells (20,000 cells).  A control sample with no LDL probe was used to define 
the autofluorescence as 98% of the control population.  The remaining 2% of the 
population of interest was defined as being significantly fluorescent and for the remaining 
fluorescently labeled cells, the % population above the threshold autofluorescence were 
Figure 7.  Visualization of FRET Probe Enzymatic Degradation via SDS-PAGE.  
Degradation was confirmed by SDS-PAGE analysis of the reaction mixture.  (A) Cathepsin B 
was the enzyme used for this gel.  (B) Trypsin was the enzyme used for this gel.  Lanes 1 and 
8 contained molecular weight standards. Lanes 2-6 contained LDL (10 µg) with a decreasing 
concentration of FRET dyes (250, 250, 25, 0, and 0 nmol of dye).  The reaction mixtures in 
lanes 2-5 also contained enzyme (0.03 µg) during incubation.  Lane 7 was a reaction mixture 
consisting of only enzyme (0.03 µg) to ensure an absence of enzyme contribution to band 
intensity. A.) Enzyme for digestion was cathepsin B. B.) Enzyme for digestion was trypsin. 
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counted.  The fluorescence mean intensity is a relative comparison of the fluorescence 
intensity above the autofluorescence of the cell.  A zero time point during the LDL 
incubation represents the fluorescently labeled LDL resting on the cell surface.  This 
LDL was cold-bound and should not have been exposed to any degrading conditions.  
The LDL probe was observed to contribute a 10.0% greater increase to the fluorescence 
(Table 1).  At 2 hours, a 92% increase in fluorescence intensity indicated degradation of 
the probes.  At 24 hours, mean intensity began to decrease to 93%, possibly indicating 
degradation of the fluorescent dyes themselves. 
 
 
Assaying Polarization of MDCK Monolayer 
Millipore Millicell transepithelial resistance (TEER) device was used to measure 
characteristic TEER values of the cell monolayer (Figure 8).  TEER values are observed 
to be very high (~500 ohms* cm2) indicating that tight junctions have formed very tightly 
regardless of seeding density.  A seeding volume of 0.50 mL was determined to be ideal 
for MDCK polarization.  Another assay for tight junction formation is the rejection of the 
fluid-phase marker rhodamine dextran.  MDCK monolayer cells were observed to reject 
almost all of the fluid phase marker (Table 1).   Additionally, immunostaining via FITC-
 
Table 1.  In vivo Quenching Probe Degradation via Flow Cytometry 
 
Probe Incubation Time % Population with Significant Fluorescence Intensity 
Fluorescence Mean 
Intensity 
t = 0 10% 128 
t = 2 hr 92% 474 
t = 24 hr 93% 337 
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conjugated-α-tubulin was used to look for characteristic reorganization of the 
microtubule cytoskeleton (Figure 9).  A monolayer integrity test using rhodamine-dextran 
was also used to assess integrity of the tight junctions (Table 1).  All the results indicate 












Figure 8.  MDCK TEER values over Time.  As MDCK forms a tight monolayer 
with numerous tight junctions, TEER values are observed to initially increase before 
plateuing.   






































Table 2. Rhodamine-Dextran Rejection Assay 
 
Cell Seeding Volume (mL) Average % Rejected 
0.1 97.27% 
1.0 99.95% 
Figure 9.  Images of Microtubule Reorganization after Polarization.  Polarized 
cells have been observed to undergo microtubule reorganization.  (A) In an 
unpolarized cell, microtubules are are aligned horizontally to the cell surface and 
observed as long linear stretches of microtubules. (B) In polarized cells, 
microtubules align themselves vertically and are viewed as short small specks of 





  The purpose of the research was to investigate the functionality of two 
fluorescent LDL probes.  These probes were designed to be sensitive to intracellular 
degradation so that degradative pathways and transcytic pathways could be differentiated.  
The biological significance of LDL in cholesterol transport has yielded interest in LDL as 
a cargo.  Additionally, insight into how transcytosis occurs has enormous medical 
potential.  Sensitive fluorescent techniques, such as FRET and fluorescence quenching, 
are poised to become a comprehensive labeling technique for cholesterol-representative, 
dynamic, well-resolved imaging that confers structural characteristics of single particles.   
The detergent degradation indicated high probe functionality.  However, the in 
vitro enzymatic degradation of the LDL probes was not consistent with detergent 
degradation or in vivo flow cytometry results.  This is hypothesized to be an artifact of 
artificial degradation of the LDL.  Physiologically, LDL would be exposed to numerous 
proteases that act in a concerted effort to degrade the particle.  The single enzyme 
experiments are far removed from the normal degradation of LDL, and increasing 
concentration of the enzyme still displayed a saturating amount of enzyme activity (data 
not shown).  Flow cytometry depicted the in vivo functionality of this probe. 
The change in fluorescent activity for both probes should be easily tracked during 
in vivo imaging.  Additionally, further characterization of the LDL particles’ mass and 
size distribution through dynamic light scattering and electron microscopy would allow 
for a more quantitative description of how FRET and fluorescence quenching 
mechanisms rely on a changing surface area to volume ratio.  Other results indicate a 
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much more complex interaction of the dyes in the LDL environment.  Much of the data 
provides evidence that the dye may be altering normal LDL interactions, or that LDL 
interactions are altering dye spectral properties.  The implications for this discovery are 
substantial since similarly 1-color labeled LDL is the current standard for observing LDL 
inter- and intra-cellular localization (13). Previous data demonstrates that labeled LDL is 
inhibited and displaced by a competing concentration of unlabeled LDL when observing 
cell surface interactions (14). 
This concern was first encountered when the dye was found to alter the 
absorbance peak of the protein at 271 nm.  An initial hypothesis involved the fluorophore 
inducing protein conformational changes and changing the local environment of 
apolipoprotein B100’s aromatic groups.   However, no change in banding pattern 
between labeled and unlabeled LDL was observed after chymotrypsin degradation, 
showing that vulnerability of the aromatic residues was not significantly impacted by the 
dye (data not shown).  Additionally, all of the enzymes behaved consistently between the 
labeled and unlabeled dyes, indicating that overall protein conformation was consistent 
enough for proper degradation.  
Although the dye and the LDL particle seem to have indiscernible interactions, 
observation of LDL degradation via FRET and fluorescence quenching was still possible.  
Under the determined concentration, FRET donor emission was significantly increased 
while acceptor emission decreased.  Similarly, over a magnitude increase in fluorescence 
intensity was observed for the fluorescence quenching probe.  These probes have proven 
themselves in a control detergent degradation assay as well as in vivo flow cytometry 














  Future work will involve further characterizing the in vivo applications of the two 
probes.   Flow cytometry experiments that measure probe functionality require a finer 
range of time points.  This will allow the degradation of the fluorescent probes to be 
tracked in vivo in a bulk cell sample.  Additionally, specific cell behavior-altering 
reagents will be able to verify the location of the probe.  This includes using wortmannin 
to inhibit endosome-lysosome fusion in order to ensure degradation is occurring in the 
lysosomes.  Colocalization experiments with various vesicles can accurately identify 
subcellular regions of LDL incubation.   Single-particle tracking of LDL-containing 
vesicles will visualize temporal-spatial information on LDL degradation and transcytosis.  
This experiment determined protocols for verifiying MDCK polarization indicating a 
ready model system for single-particle tracking of the fluorescent probes.  Intracellular 
movement of the LDL particle from the endosomes to the lysosomes, a poorly 
characterized process, can now be dynamically imaged and quantified using these probes.   
This will allow for the mechanism of transcytosis to be investigated. 
This study has verified the hypothesis that both the FRET and fluorescence 
quenching probes respond significantly during LDL degradation.  As a result, the probes 
should be able to discern transcytosing LDL from degrading LDL; this function will be 
useful for elucidating the process of transcytosis.  Understanding the fundamental basics 
of transcytosis will aid in drug delivery especially in transcytosis-exclusive cells such as 
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